Marcelo Brocchi

Marcelo Brocchi

Auto-generated profile, based on publicly available information

Marcelo Brocchi

Departamento de Genética, Evolução, Microbiologia e Imunologia, Instituto de Biologia, Universidade Estadual de Campinas

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2022 in Future Microbiology
Verified
Journal Article
Closed access
PGPedro Henrique Gallo-Francisco
Pedro Henrique Gallo-Francisco
MBMarcelo Brocchi
Marcelo Brocchi
SGSELMA GIORGIO
SELMA GIORGIO
Leishmaniasis is a zoonotic and neglected disease, which represents an important public health problem worldwide. Different species of Leishmania are associated with different manifestations, and a...

1 June 2021 in Recent Patents on Biotechnology
Verified
Journal Article
Closed access
PDF file
NDNelson Duran
Nelson Duran
WFWagner José Fávaro
Wagner José Fávaro
MBMarcelo Brocchi
Marcelo Brocchi
GJGiselle Zenker Justo
Giselle Zenker Justo
Guillermo Raul CastroGuillermo Raul Castro
Guillermo Raul Castro
GNGerson Nakazato
Gerson Nakazato
Background: This review outlines the current impact of violacein-derivative materials in several technological areas through patents. Methods: A comprehensive examination of patent databases on violacein demonstrated the relevance of this pigment, as well as the pertinent topics related to its technological development in order to obtain adaptable new pharmaceuticals, cosmetics, and new quality fiber materials, together with other applications of violacein in different areas. Results: At present, there is no efficient and economical technique for violacein preparation at the industrial scale. Many attempts have been made, but none have overcome the challenge of being an effective and inexpensive process. However, some potential applications of violacein in fields such as biomedicine make the pigment worthy of continuous investigation. In particular, violacein patents covering biosynthesis for different applications have been reported recently. Conclusion: Violacein has been used as a unique pigment in distinct specialty areas, such as in medical and industrial fields. This review of patents provides an update on violacein innovations that are useful for researchers working in the expanding and interesting field of biotechnology with natural pigments.

7 April 2026 in Microbiology Spectrum
Verified
Journal Article
Open access
NDNatália Carolina Drebes Dörr
Natália Carolina Drebes Dörr
BRBárbara Bortolozzo Ribeiro
Bárbara Bortolozzo Ribeiro
ASArthur Henrique Barrios Solano
Arthur Henrique Barrios Solano
IGIsabella Carolina Rodrigues dos Santos Goes
Isabella Carolina Rodrigues dos Santos Goes
FRFrancine Coelho Rosa
Francine Coelho Rosa
CACristina E. Alvarez-Martinez
Cristina E. Alvarez-Martinez
The escalating global threat of antimicrobial resistance highlights the urgency of understanding pathogens like Stenotrophomonas maltophilia , an intrinsically multidrug-resistant opportunistic bacterium. While increasingly isolated in nosocomial infections, S. maltophilia is also ubiquitous in diverse environmental settings. Crucially, in both clinical and environmental niches, this bacterium thrives within polymicrobial communities, making its interactions with other microorganisms particularly significant. However, the cooperative and competitive dynamics within these communities, which could be used in innovative therapeutic strategies, are largely unexplored. Our study investigated the prevalence, functional contribution, and effector diversity of the type VI secretion system (T6SS), a powerful bacterial molecular weapon, in a collection of clinical and environmental Brazilian S. maltophilia isolates. Through whole-genome sequencing, comparative genomics, and functional assays, we found that T6SS clusters, predominantly of the i4-clade, are present in a small but lineage-specific subset of isolates. Notably, one clinical strain also harbored an additional i3-clade T6SS. Interbacterial competition assays against Escherichia coli showed significant variations in killing efficacy, with a subset of isolates from the Sgn4 monophyletic lineage exhibiting robust antibacterial activity and increased pathogenicity in a Galleria mellonella infection model. Importantly, genetic dissection demonstrated that both phenotypes were T6SS-dependent. Further analysis of T6SS effector profiles identified diverse toxin-immunity pairs, including predicted pore-forming toxins and peptidoglycan hydrolases, correlating with observed phenotypes and suggesting possible anti-eukaryotic potential. Our results underscore the complex genomic variability and ecological strategies of the S. maltophilia complex (Smc), highlighting the T6SS’s importance as a mediator of competition. IMPORTANCE: Stenotrophomonas maltophilia is an emerging opportunistic pathogen associated with severe nosocomial infections with limited treatment options due to resistance to multiple antibiotics. Mechanisms of pathogenicity and fitness are relatively poorly understood in the species, which is ubiquitous in the environment and shows high genome plasticity. Type VI secretion systems (T6SS) are molecular machines that inject effector proteins into target cells, playing fundamental roles in bacterial interactions within polymicrobial communities and hosts. In this study, we identify and characterize T6SSs in a diverse set of clinical and environmental isolates of S. maltophilia from Brazil, revealing their role in bacterial antagonism and virulence. This study provides new insights into the mechanisms that contribute to S. maltophilia ’s ability to thrive in distinct environments, also contributing to the understanding of the complex genomic variability within the species.

2 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PGPriscila Jane Romano de Oliveira Gonçalves
Priscila Jane Romano de Oliveira Gonçalves
CHCarmen C. Denman Hume
Carmen C. Denman Hume
AFAlmir José Ferreira
Almir José Ferreira
STSarina Tsui
Sarina Tsui
MBMarcelo Brocchi
Marcelo Brocchi
WAWelington Luiz Araújo
Welington Luiz Araújo
Burkholderia seminalis strain TC3.4.2R3 is an endophytic bacterium isolated from sugarcane roots that produces antimicrobial compounds, facilitating its ability to act as a biocontrol agent against phytopathogenic bacteria. In this study, we investigated the thermoregulation of B. seminalis TC3.4.2R3 at 28 °C (environmental stimulus) and 37 °C (host-associated stimulus) at the transcriptional and phenotypic levels. The production of biofilms and exopolysaccharides such as capsular polysaccharides and the biocontrol of phytopathogenic fungi were enhanced at 28 °C. At 37 °C, several metabolic pathways were activated, particularly those implicated in energy production, stress responses and the biosynthesis of transporters. Motility, growth and virulence in the Galleria mellonella larvae infection model were more significant at 37 °C. Our data suggest that the regulation of capsule expression could be important in virulence against G. mellonella larvae at 37 °C. In contrast, B. seminalis TC3.4.2R3 failed to cause death in infected BALB/c mice, even at an infective dose of 107 CFU.mL−1. We conclude that temperature drives the regulation of gene expression in B. seminalis during its interactions with the environment.

10 September 2025 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Open access
Genesy Pérez JorgeGenesy Pérez Jorge
Genesy Pérez Jorge
Marco Tulio Pardini GontijoMarco Tulio Pardini Gontijo
Marco Tulio Pardini Gontijo
MSMarina Flóro e Silva
Marina Flóro e Silva
RLRaquel Bester Liszbinski
Raquel Bester Liszbinski
RTRenata Spagolla Napoleão Tavares
Renata Spagolla Napoleão Tavares
MBMarcelo Brocchi
Marcelo Brocchi
Violacein exhibits antitumor activity, indicating potential for future clinical application. However, an efficient delivery system is required for the clinical use of this hydrophobic compound. Effective delivery systems can enhance the solubility and bioavailability of hydrophobic compounds like violacein, facilitating its clinical application for antitumor therapy. Recent studies have demonstrated that outer membrane vesicles (OMVs) can serve as nanocarriers. This article constitutes the first report to present both in vivo and in vitro investigations of OMVs derived from a hypervesiculating mutant of Salmonella enterica Typhimurium as a delivery vehicle for violacein. In this study, S. enterica Typhimurium ΔtolRA (with a hypervesiculated phenotype) was transformed with a plasmid encoding the violacein biosynthesis operon. OMVs and violacein-loaded OMVs were isolated, characterized, and used in the treatment of murine melanoma. We assessed the cytotoxic effect of these violacein-loaded OMVs in both two-dimensional (2D) and three-dimensional (3D) cell cultures. Violacein-loaded OMVs reduced melanoma cell viability (IC50: 9.30 × 108 vesicles/mL) and delivered violacein in melanoma cells. Additionally, tumor regression was associated with treating tumor-bearing mice with violacein-loaded OMVs or nonviolacein-loaded OMVs (5 × 109 vesicles/mouse). The antitumor response was linked to the accumulation of M1-type macrophages in the tumor microenvironment and the overexpression of mRNA for antitumor mediators Inducible Nitric Oxide Synthase, Tumor Necrosis Factor-alpha, and Interleukin-6 (iNOS, TNF-α, and IL-6). Our results suggest that OMVs can act as nanocarriers for highly hydrophobic agents and induce antitumor responses to eliminate tumors.

13 October 2022 in Brazilian Journal of Analytical Chemistry
Verified
Journal Article
Closed access
MFMilena Fernandes
Milena Fernandes
ACAndre Luiz Melo Camelo
Andre Luiz Melo Camelo
PVPedro Vendramini
Pedro Vendramini
MBMarcelo Brocchi
Marcelo Brocchi
ASAna Valéria Colnaghi Simionato
Ana Valéria Colnaghi Simionato
The inappropriate and excessive use of antibiotics for the treatment of bacterial infections has led to the increasing presence of resistant and multidrug-resistant bacteria both in hospital settings and in the community. Thus, understanding the metabolism of resistant bacteria is extremely important to combat them more efficiently. In this scenario, mass spectrometry imaging (MSI) is considered a promising technique for understanding the resistant characteristics of such bacteria and how they can potentially be treated. This process consists of the identification of different ions on the surface of the colonies and the identification of potential metabolites that characterize antibiotic resistance, upon comparison with susceptible bacteria of the same species. This work presents matrix-assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI) study of colonies of Methicillin-resistant Staphylococcus aureus, as a proof of concept of the technique for obtaining images of bacteria colonies. Images of methicillin-resistant and susceptible colonies of Staphylococcus aureus were obtained by a sublimation process to apply the MALDI matrix on the samples followed by MALDI-MSI analysis. Seventeen (17) potential metabolites were identified and spatially localized, such as N,N-dihydroxy-L-valine, 2-(4-Methylphenyl)ethylamine, 3,4-Dihydroxy-L-phenylalanine, 2-Methyl-hexanoic acid, threonine, Arginine, Aureusimine and Glycyl-D-asparagine. Thus, this study reinforces the potential of MALDI-MSI for identification of metabolites synthesized by different strains of Staphylococcus aureus bacteria.